What Moves Like BCYC

Bicycle Therapeutics plc Pharmaceutical Preparations · Nasdaq

The tradable tickers whose daily moves track BCYC most closely over the past year, filtered to risk comparable with BCYC's own.

Closest match

SBIO ALPS Medical Breakthroughs ETF — 0.589 correlation over the past year, and 39% calmer than BCYC.

252 sessions to 2026-09-10 · BCYC volatility 51.5% annualised · $1.5M a day
Ticker 1-year correlation 3-year Volatility vs BCYC Risk What it is
SBIO ALPS Medical Breakthroughs ETF
0.589
0.477 0.61× 39% calmer Fund
DNLI Denali Therapeutics Inc.
0.495
0.368 1.09× similar Biological Products, (No Diagnostic Substances)
PCVX Vaxcyte, Inc.
0.479
0.307 0.89× 11% calmer Biological Products, (No Diagnostic Substances)
MGTX MeiraGTx Holdings plc
0.467
0.289 1.16× 16% choppier Biological Products, (No Diagnostic Substances)
ARKG ARK Genomic Revolution ETF
0.467
0.364 0.87× 13% calmer Fund
RCKT Rocket Pharmaceuticals, Inc.
0.459
0.322 1.39× 39% choppier Pharmaceutical Preparations
NRIX Nurix Therapeutics, Inc.
0.449
0.338 1.17× 17% choppier Pharmaceutical Preparations
VKTX Viking Therapeutics, Inc.
0.447
0.263 1.16× 16% choppier Pharmaceutical Preparations
ARVN Arvinas, Inc.
0.447
0.236 1.06× similar Pharmaceutical Preparations
KURA Kura Oncology, Inc.
0.444
0.285 1.18× 18% choppier Pharmaceutical Preparations
VIR Vir Biotechnology, Inc.
0.440
0.220 1.27× 27% choppier Biological Products, (No Diagnostic Substances)
ABEO Abeona Therapeutics Inc.
0.431
0.243 1.05× similar Pharmaceutical Preparations
IMTX Immatics N.V.
0.430
0.340 1.20× 20% choppier Biological Products, (No Diagnostic Substances)
ALT Altimmune, Inc.
0.430
0.213 1.34× 34% choppier Pharmaceutical Preparations
RXRX Recursion Pharmaceuticals, Inc.
0.426
0.316 1.40× 40% choppier Biological Products, (No Diagnostic Substances)
SLDB Solid Biosciences Inc.
0.424
0.284 1.55× 55% choppier Biological Products, (No Diagnostic Substances)
NKTX Nkarta, Inc.
0.423
0.289 1.46× 46% choppier Pharmaceutical Preparations
STOK Stoke Therapeutics, Inc.
0.420
0.263 1.14× 14% choppier Pharmaceutical Preparations
CLDX Celldex Therapeutics, Inc.
0.420
0.293 0.98× similar In Vitro & In Vivo Diagnostic Substances
FDMT 4D Molecular Therapeutics, Inc.
0.417
0.257 1.56× 56% choppier Biological Products, (No Diagnostic Substances)
ARKK ARK Innovation ETF
0.411
0.294 0.74× 26% calmer Fund
IMVT Immunovant, Inc.
0.402
0.231 1.17× 17% choppier Biological Products, (No Diagnostic Substances)
CRBU Caribou Biosciences, Inc.
0.402
0.298 1.43× 43% choppier Biological Products, (No Diagnostic Substances)
RCUS Arcus Biosciences, Inc.
0.400
0.363 1.20× 20% choppier Pharmaceutical Preparations
CRBP Corbus Pharmaceuticals Holdings, Inc.
0.398
0.204 1.58× 58% choppier Pharmaceutical Preparations

Showing 25 of 30 tickers that qualified. Correlation is of daily returns; 1.000 would mean moving in lockstep, 0.000 no relationship at all.

What this is for

Three questions, one number behind all of them.

How to read the two correlation columns

The one-year figure is what the relationship looks like now. The three-year figure is what it has looked like over a longer stretch. Comparing them is the point: when they agree, the relationship is structural and likely to hold. When the one-year number is far below the three-year one, something has changed — a shift in business mix, an index reconstitution, a sector that has stopped moving together — and the recent figure is the one to trust less, not more.

Correlation measures whether two things move together, not whether they move by the same amount. That is why the volatility column is there. Two tickers can correlate at 0.99 while one swings half again as hard, and swapping one for the other would quietly change how much risk you are carrying.

What was deliberately left out

Ranking purely by correlation produces answers that are mathematically perfect and practically useless. The closest matches to AAPL by raw correlation are leveraged AAPL funds at 0.999 — correct, and not replacements for anything. Four filters run before a ticker is allowed to appear:

Where all of that leaves a ticker with no close match, the page says so. A stock with no substitute is a real and useful finding, and inventing a loose one to fill the table would be worse than an empty answer.

Limits, stated up front

Where the numbers come from

Correlations are computed in-house from a daily price history and rebuilt every night. What gets published is the derived statistic — a correlation coefficient, a volatility ratio, an observation count — and nothing from which a price or return series could be reconstructed. The rest of the Markets section is on the Markets overview, including futures positioning extremes and SEC Form 4 insider transactions.